300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Social Impact
Artificial Intelligence
SaaS
Energy
Mobile
Consumer
Health Care
Platforms
Enterprise Software
Local
Travel
InsurTech
Retail
Oil and Gas
Payments
Film
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Colombia
Cameroon
Guernsey
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Namibia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Bangladesh
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Nucleus Capital, VC Fund

Nucleus Capital

VC Fund

Berlin, Germany

Nucleus Capital is a VC fund in Berlin focused on Biotechnology and Food and Beverage. Fueling pioneers, turning bold science into planetary resilience. A first check deep-tech VC focused on Programmable Biology (Synbio & TechBio), Food Technology and Green Industrials.

Total investments:
48
Last investment:
Lead investor:
33%
Fund size:
$48M
Last fund:

Last updated:

Industries Nucleus Capital invests in

BiotechnologyFood and BeverageAgricultureLife ScienceManufacturing

Stages Nucleus Capital invests in

Pre-SeedSeedSeries AConvertible NoteVenture - Series Unknown

Countries Nucleus Capital invests in

GermanyUnited KingdomUnited StatesThe NetherlandsItaly

Round sizes

Seed $3M–$8MPre-Seed $486k–$3.8MSeries A $15M–$17M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$3M–$8M
Pre-Seed
$486k–$3.8M
Series A
$15M–$17M

Investment Focus

Industry

  • Biotechnology 14 (29%)
  • Food and Beverage 6 (13%)
  • Agriculture 4 (8%)
  • Life Science 4 (8%)
  • Manufacturing 4 (8%)
See all 54 industries →

Stage

  • Pre-Seed 26 (54%)
  • Seed 13 (27%)
  • Series A 2 (4%)
  • Convertible Note 2 (4%)
  • Venture - Series Unknown 1 (2%)

Country

  • Germany 11 (23%)
  • United Kingdom 8 (17%)
  • United States 7 (15%)
  • The Netherlands 3 (6%)
  • Italy 1 (2%)
See all 11 countries →

Team

NameTitleInvestmentsLinksEmail
Carolina Villa
Carolina Villa Principal
Principal Total investments: 0
Find email
Isabella Fandrych
Isabella Fandrych Co-Founder & GP
Co-Founder & GP Total investments: 2
Find email
Martin Weber
Martin Weber Investor
Investor Total investments: 4
Find email
Maximilian Schwarz
Maximilian Schwarz Founder & GP
Founder & GP Total investments: 3
Find email

Investments

CompanyDescriptionRoundLinks
Apoha
Stealth stage start-up $36M / Venture - Series Unknown / Jun 03, 2026
Triple Bio is a biotech startup focused on improving productivity and sustainability in dairy and beef production using biological and data‑driven technologies. $1.7M / Pre-Seed / May 20, 2026
Bindbridge is an AgTech company that applies artificial intelligence to discover and design molecular glues for crop protection. The company develops computational models that identify and optimize small molecules capable of selectively binding target proteins, enabling novel modes of action against weeds and crop diseases. Its platform integratesAI-driven drug discovery techniques with plant biology and agronomic research to generate candidates intended to improve efficacy while reducing off-target impact. Bindbridge advances these molecules through laboratory validation and early-stage development processes focused on safety, performance, and environmental considerations. The company collaborates with agricultural and crop science partners to evaluate applications across herbicide and fungicide use cases. Through its AI-enabled discovery approach, Bindbridge works to expand the range of crop protection tools available for modern agriculture. $3.8M / Pre-Seed / Mar 03, 2026
Biographica is a computational biology company that develops software tools and platforms to support genomic data analysis, interpretation, and visualization for research and clinical applications. Its solutions are designed to help scientists, clinicians, and bioinformaticians process complex genomic datasets, annotate genetic variants, andexplore biological insights through integrated workflows and interactive visualizations. The company’s platform combines data management, algorithmic analysis, and graphical interfaces to streamline tasks such as sequence alignment, variant calling, functional interpretation, and cohort comparison. Biographica’s tools support interoperability with common bioinformatics formats and pipelines, enabling users to integrate genomic workflows with existing research infrastructure. The company also provides APIs and developer tools to allow custom integration, automation, and extension of analytic capabilities within broader computational environments. Its offerings are used across life sciences research, translational projects, and precision medicine initiatives that require scalable, interpretable genomic data analysis. $9.5M / Seed / Jan 07, 2026
Endolith is a biotech company transforming sustainable mining by leveraging microbes, synthetic biology, and cloud computing to extract more critical minerals like copper from low-grade ores. Working with the many of the leading mining companies, Endolith is advancing its innovative technology to commercial scale. Recognized as a finalist in theBHP Unearthed BioMetals cohort and a member of the Alaska Critical Minerals Collaborative, Endolith is driving the future of mining with sustainable, efficient, and responsible solutions for the clean energy transition. $16.5M / Series A / Nov 05, 2025
Telura is a deep-tech business that uses next-generation drilling to enable geothermal energy everywhere. Telura creates electric impulse drilling technology, which breaks rock from within using high-voltage pulses. $4.7M / Pre-Seed / Oct 01, 2025
Vosbor is a digital grain & oilseed trading platform providing a spot and forward market to reconcile trade data & securely share documents. Convertible Note / Sep 16, 2025
ScienceMachine is an AI startup accelerating biotech data analysis with a fully autonomous agent, $3.5M / Pre-Seed / Jul 09, 2025
Koppie is a company has developed a patent-pending fermentation and roasting technology that transforms locally sourced pulses $1.6M / Pre-Seed / Jun 26, 2025
Bindbridge is an AgTech company that applies artificial intelligence to discover and design molecular glues for crop protection. The company develops computational models that identify and optimize small molecules capable of selectively binding target proteins, enabling novel modes of action against weeds and crop diseases. Its platform integratesAI-driven drug discovery techniques with plant biology and agronomic research to generate candidates intended to improve efficacy while reducing off-target impact. Bindbridge advances these molecules through laboratory validation and early-stage development processes focused on safety, performance, and environmental considerations. The company collaborates with agricultural and crop science partners to evaluate applications across herbicide and fungicide use cases. Through its AI-enabled discovery approach, Bindbridge works to expand the range of crop protection tools available for modern agriculture. $3.8M / Pre-Seed / Jun 02, 2025
See all 48 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Social Impact
Artificial Intelligence
SaaS
Energy
Mobile
Consumer
Health Care
Platforms
Enterprise Software
Local
Travel
InsurTech
Retail
Oil and Gas
Payments
Film
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Colombia
Cameroon
Guernsey
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Namibia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Bangladesh
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Nucleus Capital invest in?

Nucleus Capital invests primarily in Biotechnology, Food and Beverage and Agriculture startups, most often at Pre-Seed and Seed stage. Most of the 48 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Nucleus Capital's check size?

Nucleus Capital typically joins rounds of $3M–$8M at Seed, $486k–$3.8M at Pre-Seed and $15M–$17M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Nucleus Capital participates in.

How do I contact Nucleus Capital?

Public channels for Nucleus Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Nucleus Capital?

The team at Nucleus Capital includes Carolina Villa (Principal), Isabella Fandrych (Co-Founder & GP) and Martin Weber (Investor). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Nucleus Capital Nucleus Capital Find emails